Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

References for PMC Articles for PubMed (Select 20981240)

1.

Progestogen treatment options for early endometrial cancer.

Cade TJ, Quinn MA, Rome RM, Neesham D.

BJOG. 2010 Jun;117(7):879-84. doi: 10.1111/j.1471-0528.2010.02552.x. Epub 2010 Apr 12.

PMID:
20394609
2.

Menstrual blood loss in women using the frameless FibroPlant LNG-IUS.

Andrade A, Wildemeersch D.

Contraception. 2009 Feb;79(2):134-8. doi: 10.1016/j.contraception.2008.09.007. Epub 2008 Oct 28.

PMID:
19135571
3.

Sparing fertility in young patients with endometrial cancer.

Chiva L, Lapuente F, González-Cortijo L, Carballo N, García JF, Rojo A, Gonzalez-Martín A.

Gynecol Oncol. 2008 Nov;111(2 Suppl):S101-4. doi: 10.1016/j.ygyno.2008.07.056. Epub 2008 Sep 18. Review.

PMID:
18804267
4.

Management of patients with non-atypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: long-term follow-up.

Wildemeersch D, Janssens D, Pylyser K, De Wever N, Verbeeck G, Dhont M, Tjalma W.

Maturitas. 2007 Jun 20;57(2):210-3. Epub 2007 Jan 31.

PMID:
17270370
5.
6.

Is levonorgestrel intrauterine system effective for treatment of early endometrial cancer? Report of four cases and review of the literature.

Dhar KK, NeedhiRajan T, Koslowski M, Woolas RP.

Gynecol Oncol. 2005 Jun;97(3):924-7. Review.

PMID:
15943993
7.

Levonorgestrel-releasing intrauterine system (LNG-IUS) as a therapy for endometrial carcinoma.

Giannopoulos T, Butler-Manuel S, Tailor A.

Gynecol Oncol. 2004 Dec;95(3):762-4.

PMID:
15582001
8.

Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review.

Ramirez PT, Frumovitz M, Bodurka DC, Sun CC, Levenback C.

Gynecol Oncol. 2004 Oct;95(1):133-8. Review.

PMID:
15385122
9.

Levonorgestrel-releasing intrauterine system (Mirena) as a therapy for endometrial hyperplasia and carcinoma.

Bahamondes L, Ribeiro-Huguet P, de Andrade KC, Leon-Martins O, Petta CA.

Acta Obstet Gynecol Scand. 2003 Jun;82(6):580-2. No abstract available.

PMID:
12780432
10.
11.

Endometrial adenocarcinoma following the insertion of a Mirena IUCD.

Jones K, Georgiou M, Hyatt D, Spencer T, Thomas H.

Gynecol Oncol. 2002 Nov;87(2):216-8.

PMID:
12477456
12.

Intrauterine progesterone treatment of early endometrial cancer.

Montz FJ, Bristow RE, Bovicelli A, Tomacruz R, Kurman RJ.

Am J Obstet Gynecol. 2002 Apr;186(4):651-7.

PMID:
11967486
13.

Role of exogenous and endogenous hormones in endometrial cancer: review of the evidence and research perspectives.

Akhmedkhanov A, Zeleniuch-Jacquotte A, Toniolo P.

Ann N Y Acad Sci. 2001 Sep;943:296-315. Review.

PMID:
11594550
14.

Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD.

Nilsson CG, Haukkamaa M, Vierola H, Luukkainen T.

Clin Endocrinol (Oxf). 1982 Dec;17(6):529-36.

PMID:
6819901
15.

Treatment of endometrial hyperplasia with levonorgestrel releasing intrauterine devices.

Perino A, Quartararo P, Catinella E, Genova G, Cittadini E.

Acta Eur Fertil. 1987 Mar-Apr;18(2):137-40.

PMID:
3115027
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk